Biotechnology Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson’s Disease Study – Cerevel Therapeutics Hldg (NASDAQ:CERE) Read more
Biotechnology Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday? – Landos Biopharma (NASDAQ:LABP) Read more
Biotechnology This Analyst Is Bullish On Biohaven’s Approach in Neuro-Psych Space – Biohaven (NYSE:BHVN) Read more
Biotechnology UBS Bullish On This Depression Drug Maker, Says Alzheimer’s Agitation Data Is Attractive Catalyst – Axsome Therapeutics (NASDAQ:AXSM) Read more
Biotechnology AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall – Cerevel Therapeutics Hldg (NASDAQ:CERE), AbbVie (NYSE:ABBV) Read more
Biotechnology AbbVie’s Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures – Cerevel Therapeutics Hldg (NASDAQ:CERE), AbbVie (NYSE:ABBV) Read more
